Market Context — Why This Technology, Why Now

The global push for higher purity in advanced materials, pharmaceuticals, and specialty chemicals is intensifying, driven by stricter regulatory standards and consumer demand for superior product performance. Manufacturers face pressure to optimize production costs and reduce environmental impact while maintaining quality. This technology offers a strategic advantage by enabling more efficient, precise, and sustainable purification processes, critical for maintaining competitiveness in high-value markets.

Key Competitive Advantages
01

Achieves size-independent, high-efficiency separation of cyclic compounds, improving purity for pharmaceutical intermediates and functional materials.

02

Boosts separation efficiency by several times compared to conventional methods, enabling faster, high-purity separation and reducing production lead times.

03

Supports a wide range of cyclic compounds, enabling cross-product line efficiency in separation processes for diverse product portfolios.

Market Opportunity
💊 Pharmaceutical APIs and Intermediates Manufacturing
$3B–$3.5B globally (AI est.)
Driven by increasing demand for high-purity pharmaceuticals and pressure to optimize efficiency and reduce costs in drug manufacturing. This technology's size-independent separation enables precise purification of complex cyclic structures essential for new drug development, adding significant value.
Major pharmaceutical API manufacturers Specialty chemical producers for drug intermediates Contract manufacturing organizations (CMOs) for pharma Biotechnology companies developing novel therapeutics
🧪 High-Performance Chemicals and Materials Manufacturing
$4B–$4.5B globally (AI est.)
High-performance resins, additives, and functional polymers used in electronics, automotive, and aerospace sectors require ultra-pure cyclic raw materials. This technology has the potential to dramatically improve the production efficiency and quality of these advanced materials.
Manufacturers of high-performance polymers and resins Specialty chemical companies for advanced additives Materials science R&D divisions Automotive and aerospace material suppliers
🔬 Analytical and R&D Sector
$2.5B–$3B globally (AI est.)
There is a continuous need for high-precision separation and purification of trace cyclic compounds in new material development and biotechnology research. This technology is expected to accelerate research and facilitate new discoveries as a powerful analytical tool.
Academic research institutions and universities Biotechnology research labs Analytical instrument manufacturers Contract research organizations (CROs)
IP Defensibility — Why Competitors Can't Replicate This
What This Patent Covers

This patent broadly protects a method for separating or purifying cyclic compounds, a method for producing them, the separation material, and the separation apparatus itself, across 11 claims. The patent's stability and strength are reinforced by successfully overcoming three prior art rejections during examination, demonstrating clear differentiation from existing technologies.

Competitive White Space

This patent primarily covers the separation method and material for cyclic compounds. A licensee could develop complementary IP in advanced process integration, real-time analytics for purity control, or novel applications of the purified cyclic compounds.

Economic Impact
~$1M/year estimated purification cost reduction per facility (est.)
estimated ROI · USD · AI analysis
ROI Calculation Logic

For a plant producing 10,000 tons of chemicals annually, with conventional purification costs of ~$2M/year (AI est.), this technology could reduce costs by ~50% (AI est.) through less frequent separation material replacement, shorter processing times, and reduced solvent usage. This translates to an estimated annual cost reduction of ~$1M (AI est.).

Speed to Market
4× faster than in-house development
This technology's separation mechanism, utilizing porous channel materials, is concretely disclosed within the patent, establishing its technical principles. The detailed description of the invention includes sufficient information on material composition and apparatus structure, eliminating the need for licensees to conduct R&D from scratch. With proven principles, licensees can focus on process evaluation and optimization, significantly shortening time-to-market and potentially securing first-mover advantages.
Competitive Positioning

X: Diversity of Separated Targets
Y: Purification Efficiency and Purity

Business Models & Applications
📝 Technology Licensing
This model involves licensing the separation materials and apparatus to manufacturers of pharmaceuticals, high-performance chemicals, and food additives. Licensees can achieve higher production efficiency and product purity, securing a competitive edge.
📦 Productization of Separation Materials & Apparatus
Develop and manufacture separation materials and apparatus based on this technology as products, selling them directly to pharmaceutical companies, chemical plants, and research institutions. Offer highly customizable products to meet specific customer needs.
🧪 Contract Purification Services
Provide contract separation and purification services for cyclic compounds. Operate high-precision separation technology in-house to meet the needs for difficult-to-purify special compounds or high-mix, low-volume production, securing a new revenue stream.
Adjacent Application Opportunities
🧬 Biopharmaceuticals
High-Precision Biopharmaceutical Purification
Applicable to purifying cyclic biopharmaceuticals like peptides and nucleic acid drugs, not just small molecule drugs. This could significantly improve impurity separation, enhancing product safety and efficacy, potentially increasing new drug development success rates. It is also expected to facilitate compliance with GMP requirements.
♻️ Environmental & Recycling
Selective Removal of Environmental Pollutants
This technology could be applied to selectively adsorb and separate specific cyclic environmental pollutants (e.g., endocrine disruptors, persistent organic pollutants) from water or soil. Its high selectivity and efficiency could enable the removal of trace contaminants previously difficult to address, revolutionizing environmental remediation processes with up to 90% removal efficiency.
💻 Electronics
Ultra-High Purity Semiconductor Materials
In semiconductor manufacturing, this technology could purify photoresist materials and organic EL materials by removing cyclic impurities to extremely low levels. Ultra-high purity materials are essential for increasingly miniaturized device manufacturing, contributing to improved yields and stabilized product performance, potentially reducing defect rates by ~30%.
Integration Roadmap — Estimated 18-Month Deployment
Initial Validation and Design
Duration: 3 months
Evaluate compatibility with the licensee's existing processes and design the optimal configuration for this technology's porous channel materials and separation apparatus. Conduct small-scale bench validation of performance.
Pilot Plant Implementation and Optimization
Duration: 6 months
Based on the design, build and demonstrate a pilot-scale system. Verify separation efficiency, throughput, and durability, then optimize operational parameters for stable performance.
Full-Scale Deployment and Mass Production Integration
Duration: 9 months
Leveraging pilot results, proceed with full-scale technology integration into actual production lines and mass production systems. Establish stable supply of high-purity products and accelerate market launch.
Technical Feasibility
This technology can be integrated into existing separation and purification equipment by filling with porous channel materials or replacing parts of existing filtering systems. The patent claims include configurations for separation materials and apparatus, allowing for physical module replacement and optimization of flow path design. It offers technical flexibility for relatively easy process integration without requiring extensive capital investment.
Success Scenario
Upon implementing this technology, a licensee's chemical plant or pharmaceutical manufacturing line could see a 1.5x improvement in the processing capacity of its cyclic compound purification step. This could lead to increased manufacturing throughput and the stable supply of higher-purity products, thereby establishing a competitive advantage in the market.
Patent Record
APPLICATION NO.
特願2020-035291
REGISTRATION NO.
7456085
FILING DATE
2020年03月02日
GRANT DATE
2024年03月18日
EXPIRATION DATE
2040年03月02日
PATENT HOLDER
国立大学法人　東京大学
Examination History
2023年03月01日
出願審査請求書
2023年10月03日
拒絶理由通知書
2023年11月30日
意見書
2023年11月30日
手続補正書（自発・内容）
2024年02月06日
特許査定